Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial - Summary - MDSpire

Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial

  • By

  • Y. J. L. Bodar

  • B. H. E. Jansen

  • J. P. van der Voorn

  • G. J. C. Zwezerijnen

  • D. Meijer

  • J. A. Nieuwenhuijzen

  • R. Boellaard

  • N. H. Hendrikse

  • O. S. Hoekstra

  • R. J. A. van Moorselaar

  • D. E. Oprea-Lager

  • A. N. Vis

  • October 20, 2020

  • 0 min

Share

Objective:

To assess the accuracy of 18F-DCFPyL-PET/CT in localizing primary prostate cancer (PCa) and to evaluate its potential for guiding targeted biopsies, which may improve patient outcomes.

Key Findings:
  • 18F-DCFPyL-PET/CT demonstrated high accuracy in localizing primary prostate tumors, with sensitivity and specificity rates reported at 98-100%.
  • Detection rates for primary PCa were reported at 98-100%.
  • The imaging technique showed potential for guiding targeted biopsies.
Interpretation:

The study suggests that PSMA-PET/CT can improve the accuracy of prostate cancer detection and may enhance the precision of targeted biopsies compared to traditional methods.

Limitations:
  • The study was conducted at a single center, which may limit generalizability and the applicability of results to broader populations.
  • The sample size and duration of follow-up were not specified.
Conclusion:

18F-DCFPyL-PET/CT is a promising tool for the localization of prostate cancer and may facilitate more accurate targeted biopsies, warranting further investigation in larger cohorts to validate these findings.

Original Source(s)

Detection of prostate cancer with 18F-DCFPyL PET/CT compared to final histopathology of radical prostatectomy specimens: is PSMA-targeted biopsy feasible? The DeTeCT trial

  • by Y. J. L. Bodar, B. H. E. Jansen, J. P. van der Voorn, G. J. C. Zwezerijnen, D. Meijer, J. A. Nieuwenhuijzen, R. Boellaard, N. H. Hendrikse, O. S. Hoekstra, R. J. A. van Moorselaar, D. E. Oprea-Lager, A. N. Vis

  • October 20, 2020

Related Content

Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma

Local staging with multiparametric MRI in daily clinical practice: diagnostic accuracy and evaluation of a radiologic learning curve

Confocal laser endomicroscopy for upper tract urothelial carcinoma: validation of the proposed criteria and proposal of a scoring system for real-time tumor grading